User profiles for M. Sue O'Dorisio
M Sue O'DorisioProfessor of Pediatrics, University of Iowa Verified email at uiowa.edu Cited by 10097 |
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
…, HJ Su Huang, NJ Petrelli, X Zhang, MS O'Dorisio… - Nature …, 2000 - nature.com
CpG islands frequently contain gene promoters or exons 1 and are usually unmethylated in
normal cells 1, 2, 3. Methylation of CpG islands is associated with delayed replication, …
normal cells 1, 2, 3. Methylation of CpG islands is associated with delayed replication, …
The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma …
Pheochromocytomas, intra-adrenal paraganglioma, and extra-adrenal sympathetic and
parasympathetic paragangliomas are neuroendocrine tumors derived from adrenal chromaffin …
parasympathetic paragangliomas are neuroendocrine tumors derived from adrenal chromaffin …
[HTML][HTML] 90Y-edotreotide for metastatic carcinoid refractory to octreotide
DL Bushnell Jr, TM O'Dorisio, MS O'Dorisio… - Journal of Clinical …, 2010 - ncbi.nlm.nih.gov
Purpose Metastatic carcinoid is an incurable malignancy whose symptoms, such as diarrhea
and flushing, can be debilitating and occasionally life-threatening. Although symptom relief …
and flushing, can be debilitating and occasionally life-threatening. Although symptom relief …
Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan)
…, RV Pozderac, G Hinkle, T Hill, TM O'Dorisio… - Seminars in nuclear …, 1995 - Elsevier
Somatostatin, a naturally occurring 14-amino acid peptide, can be thought of as an anti-growth
hormone and functional down-regulator of sensitive tissue. Most neuroendocrine tumors …
hormone and functional down-regulator of sensitive tissue. Most neuroendocrine tumors …
Somatostatin inhibits IGF-1 mediated induction of VEGF in human retinal pigment epithelial cells
JW Sall, DD Klisovic, MS O'Dorisio, SE Katz - Experimental eye research, 2004 - Elsevier
Neovascularization stimulated by IGF-1 mediated induction of vascular endothelial growth
factor (VEGF) is one of the leading causes of blindness in humans. It plays a central role in the …
factor (VEGF) is one of the leading causes of blindness in humans. It plays a central role in the …
Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975–2006
P Navalkele, MS O'Dorisio, TM O'Dorisio… - Pediatric blood & …, 2011 - Wiley Online Library
Background The incidence, survival, and prevalence of neuroendocrine tumors (NETs) in
children were determined as a first step in improving diagnosis and therapy. Outcomes were …
children were determined as a first step in improving diagnosis and therapy. Outcomes were …
Single time point dose estimate for exponential clearance
…, Y Menda, TM O'Dorisio, MS O'Dorisio - Medical …, 2018 - Wiley Online Library
… & Yusuf Menda (PIs) and 5 P50 CA174521-03, M. Sue O'Dorisio (PI). In addition, we also
acknowledge the efforts of the team that participated in the 90 Y DOTATOC project at the …
acknowledge the efforts of the team that participated in the 90 Y DOTATOC project at the …
Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors
…, JC Carr, D Wang, MS O'Dorisio, TM O'Dorisio… - Surgery, 2013 - Elsevier
Background Ligands binding the somatostatin receptor type 2 (SSTR2) are useful for imaging
and treatment of neuroendocrine tumors (NETs), but not all tumors express high levels of …
and treatment of neuroendocrine tumors (NETs), but not all tumors express high levels of …
Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptors
…, M Connolly, J Babich, T O'Dorisio… - Journal of Nuclear …, 2010 - Soc Nuclear Med
The purpose of this study was to conduct a phase I trial of 90 Y-DOTATOC to determine the
dose-toxicity profile in children and young adults with somatostatin receptor–positive tumors. …
dose-toxicity profile in children and young adults with somatostatin receptor–positive tumors. …
Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells
…, MS O'Dorisio, TM O'Dorisio… - The Journal of …, 2001 - journals.aai.org
Vasoactive intestinal peptide (VIP) has potent antiproliferative and anti-inflammatory
functions in the immune system. Two structurally distinct G-protein-associated receptors, VIP …
functions in the immune system. Two structurally distinct G-protein-associated receptors, VIP …